Class Action Filed Against Centene Corporation (CNC) - September 8, 2025 Deadline to Join - Contact Levi & Korsinsky
Werte in diesem Artikel
NEW YORK, July 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Centene investors who were adversely affected by alleged securities fraud between December 12, 2024 and June 30, 2025. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=157025&wire=4
CNC investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Centene's enrollment and morbidity rates. Investors began to question the veracity of defendants' public statements on July 1, 2025, when Centene issued a press release withdrawing 2025 guidance. Particularly, following an analysis of the 2025 Health Insurance Marketplace, Centene's overall market growth across 22 states, or 72% of the Company's marketplace membership, was lower than expected. In pertinent part, the Company stated that this preliminary analysis resulted in a reduction of its previously issued guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75. Following this news, Centene's common stock declined dramatically, from a closing market price of $56.65 per share on July 1, 2025, Centene's stock price fell to $33.78 per share on July 2, 2025, a decline of 40.4%.
WHAT'S NEXT? If you suffered a loss in Centene during the relevant time frame, you have until September 8, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/class-action-filed-against-centene-corporation-cnc---september-8-2025-deadline-to-join--contact-levi--korsinsky-302508358.html
SOURCE Levi & Korsinsky, LLP
Übrigens: Centene und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Centene
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Centene
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Centene Corp.
Analysen zu Centene Corp.
Datum | Rating | Analyst | |
---|---|---|---|
20.10.2017 | Centene Outperform | BMO Capital Markets | |
05.04.2017 | Centene Buy | Deutsche Bank AG | |
08.02.2017 | Centene Overweight | Barclays Capital | |
07.02.2017 | Centene Overweight | Cantor Fitzgerald | |
20.06.2016 | Centene Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
20.10.2017 | Centene Outperform | BMO Capital Markets | |
05.04.2017 | Centene Buy | Deutsche Bank AG | |
08.02.2017 | Centene Overweight | Barclays Capital | |
07.02.2017 | Centene Overweight | Cantor Fitzgerald | |
20.06.2016 | Centene Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
15.06.2015 | Centene Hold | Deutsche Bank AG | |
15.06.2015 | Centene Mkt Perform | FBR Capital | |
28.04.2015 | Centene Mkt Perform | FBR Capital | |
11.02.2015 | Centene Neutral | UBS AG | |
15.12.2014 | Centene Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
05.12.2006 | Update Centene Corp.: Sell | Goldman Sachs | |
12.06.2006 | Update Centene Corp.: Sell | Matrix Research |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Centene Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen